CoChat

ImmunoCAPTM Phadiatop® Infant – a new blood test for detecting IgE sensitisation in children at 2 years of age

Ballardini, N., Nilsson, C., Nilsson, M., Lilja, G. · 2006 · Allergy
Cited by 93

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background: Correct diagnosis of immunoglobulin E (IgE)‐mediated disease is the prerequisite for secondary allergy prevention during early childhood. Objective: To evaluate the diagnostic efficacy of a new blood test, Phadiatop® Infant, in detecting IgE sensitisation to food and inhalant allergens among children at 2 years of age. Methods: Children (n = 239) were followed prospectively from birth to 2 years of age for the presence of IgE sensitisation and the development of atopic manifestations. Immunoglobulin E sensitisation was evaluated by skin prick test (SPT) and analysis of allergen‐specific IgE antibodies in plasma to food and inhalant allergens. The children were classified into three groups: IgE‐sensitised, non‐IgE sensitised and inconclusive, depending on SPT and allergen‐specific IgE results. Results: Twenty‐six (11%) of the children were classified as IgE‐sensitised, 182 (76%) as non‐IgE sensitised and 31 (13%) as inconclusive. Phadiatop Infant was positive in 50 (21%) of the children. Ten children (4%) with identified IgE antibodies against the selected food and inhalant allergens showed negative Phadiatop Infant. Three children showed positive Phadiatop Infant but were negative in the other tests performed. These results correspond to positive and negative predictive values for Phadiatop Infant of 89 and 99%, respectively. Children with clinical symptoms of atopic diseases had significantly increased levels for Phadiatop Infant (P < 0.01). Conclusion: Phadiatop Infant appears to be a reliable alternative to SPT and the measurement of allergen‐specific IgE antibodies in plasma for detecting clinically important IgE sensitisation among children at 2 years of age.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1398-9995.2005.00936.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 93

Metadata

Authors
Ballardini, N., Nilsson, C., Nilsson, M., & Lilja, G.
Venue
Allergy
Publisher
Wiley
Published
2006-01-23
Volume
61
Issue
3
Pages
337-343
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2171245377
Cited by
93
References
3
FWCI
2.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ImmunoCAPTM Phadiatop® Infant – a new blood test for detecting IgE sensitisation in children at 2 years of age. https://app.cochat.ai/papers/10.1111/j.1398-9995.2005.00936.x
The paper
Ballardini, N., Nilsson, C., Nilsson, M., & Lilja, G. (2006). ImmunoCAPTM Phadiatop® Infant – a new blood test for detecting IgE sensitisation in children at 2 years of age. Allergy. https://doi.org/10.1111/j.1398-9995.2005.00936.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.